Howard Marks - Oaktree Capital Management
Holding/activity history for Sorrento Therapeutics (SRNE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q2 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2023 Q1 | 134,000 | 0.00 | $0.36 | ||
| 2022 Q4 | 134,000 | 0.00 | $0.88 | ||
| 2022 Q3 | 134,000 | 0.00 | $1.57 | ||
| 2022 Q2 | 134,000 | 0.00 | Reduce 10.67% | 0.00 | $2.01 |
| 2022 Q1 | 150,000 | 0.00 | $2.33 | ||
| 2021 Q4 | 150,000 | 0.01 | Add 11.94% | 0.00 | $4.65 |
| 2021 Q3 | 134,000 | 0.02 | $7.63 | ||
| 2021 Q2 | 134,000 | 0.02 | Reduce 58.13% | 0.03 | $9.68 |
| 2021 Q1 | 320,000 | 0.05 | Buy | 0.05 | $8.27 |
| 2020 Q3 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2020 Q2 | 100,500 | 0.02 | Buy | 0.02 | $6.28 |